URINE DRUG TESTING for pain management may be a challenging business for clinical labs given that compliance officers in the states and in the federal government have successfully pursued lab compliance abuses in this line of business in recent years. Now comes news that private equity firm Ampersand Capital Partners of Wellesley, Massachusetts, is to […]
- "Lab M&A Update"
Ampersand Buys Calloway Labs, Enters Pain Management Market
Acquisition gives Ampersand a stake in lab test niche that has had Medicare/Medicaid compliance issues
- By Robert Michel
- > From the Volume XIX No. - October 8, 2012 Issue
- Tags: aco, cap, clinical lab, clinical lab test, clinical lab testing, Clinical Laboratory, clinical laboratory test, clinical laboratory testing, clinical labs, clinical science lab, diagnostic lab, diagnostic laboratory, genomics, lab compliance, lab executive, lab test, lab testing, lab testing companies, lab tests, laboratories, laboratory company, laboratory medicine, laboratory test, laboratory testing, medicaid fraud, medical lab, Medical laboratory, Medicare, pathologists
